NCT05080803View on ClinicalTrials.gov

Diabetic Macular Edema: Relevance of Staging Progression on Therapeutic Outcome

CompletedOBSERVATIONAL
Enrollment

608

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

December 23, 2021

Study Completion Date

July 26, 2022

Conditions
Diabetic Macular Edema
Interventions
DRUG

intravitreal administration of bevacizumab/ranibizumab/aflibercept/desamethazone

intravitreal administration

Trial Locations (1)

CH-6901

ESASO Scientific Projects, Lugano

All Listed Sponsors
lead

European School of Advanced Studies in Ophthalmology

OTHER